Inebilizumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323509)

Recombinant humanized monoclonal antibody to CD19 for ELISA, FACS, Functional Assay and In Vivo.

Freight Charges
Lead Time
7-10 Business Days
Telephone
+1 (314) 370-6046
Mon - Fri, 8am - 4pm AST
Email
orders@antibodies.com
Name
Inebilizumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free
Description
Recombinant humanized monoclonal antibody to CD19.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 146.5 kDa.
Purity
> 95% (by SDS-PAGE).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
Antibody deficiency due to defect in CD19, included, AW495831, B lymphocyte antigen CD19, B lymphocyte surface antigen B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B4, CD19 antigen, CD19 molecule, Cd19 protein, CD19_HUMAN, CVID3, Differentiation antigen CD19, Leu 12, Leu-12, Leu12, MGC109570, MGC12802, T-cell surface antigen Leu-12
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Inebilizumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323509)? Please let us know so that we can list the citation on this page.

Alternative products to Inebilizumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323509)

Top